Intelligent Medicine Acquisition Corp (IQMD) |
|
|
|
Intelligent Medicine Acquisition Growth Comparisons
Select each growth Category to receive further Information
Select the Comparisons :
|
|
Select the Ratio:
|
|
IQMD's Growth Comparisons in IV. Quarter 2022
Intelligent Medicine Acquisition reported top-line of $ 0 millions in the forth quarter 2022, compare to $ 0 millions in the same quarter a year ago. Revenues in the Blank Checks industry fell by %, while the top-line in the Financial sector decreased by %, and overall market improved by 5.63% from the forth quarter 2021. Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the forth quarter 2022 earnings reports, average yearly sales growth is 11.17%.
Growth Rates of IQMD's Income in the forth quarter 2022
IQMD's EPS Growth Rates
Intelligent Medicine Acquisition reported bottom-line of $ 0.08 in the forth quarter, compare to $ 0.00 in the same quarter a year ago. Blank Checks industry fell by %, while Financial sector decreased by -40.05%, and overall market declined by -19.16%. Comparing the company's EPS to the third quarter results, income per share were lower by -23.19% . On the annual basis, average annual income per share growth for Intelligent Medicine Acquisition is %, while S & P 500's including only Businesses with the forth quarter 2022 financial reports, average yearly income per share growth is 3.14% over the past five years.
IQMD Cash Flow Growth Rates
|